FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation
Ontology highlight
ABSTRACT: Single-arm, multi-centre phase II study The primary objective is to evaluate the time to failure of the strategy.
DISEASE(S): Adenocarcinoma,Metastatic Colorectal Cancer
PROVIDER: 2277501 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA